Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CEVA
|
Maria Marced
Director |
SELL
Open market or private sale
|
Direct | 369 Reduced 3.4% |
$25,830
$70.0 p/Share
|
Feb 18
2021 |
|
CEVA
|
Eliyahu Ayalon
Director |
SELL
Open market or private sale
|
Direct | 18,177 Reduced 68.32% |
$1,226,039
$67.45 p/Share
|
Feb 18
2021 |
|
CEVA
|
Issachar Ohana
EVP Worldwide Sales |
SELL
Open market or private sale
|
Direct | 5,901 Reduced 6.79% |
$398,908
$67.6 p/Share
|
Feb 18
2021 |
|
CEVA
|
Michael Boukaya
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,941 Reduced 3.56% |
$131,095
$67.54 p/Share
|
Feb 18
2021 |
|
NFBK
|
Robin Lefkowitz
EVP |
SELL
Open market or private sale
|
Direct | 184 Reduced 0.82% |
$2,455
$13.34 p/Share
|
Feb 18
2021 |
|
NFBK
|
Tara L French
EVP/Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 227 Reduced 1.26% |
$3,026
$13.33 p/Share
|
Feb 18
2021 |
|
NFBK
|
William R. Jacobs
EVP & PAO |
SELL
Open market or private sale
|
Direct | 241 Reduced 0.49% |
$3,213
$13.33 p/Share
|
Feb 18
2021 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.49% |
$422,450
$84.49 p/Share
|
Feb 18
2021 |
|
NRIX
|
Hans Van Houte
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 13,583 Reduced 100.0% |
$489,803
$36.06 p/Share
|
Feb 18
2021 |
|
NRIX
|
Christine Ring
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 100.0% |
$71,580
$35.79 p/Share
|
Feb 18
2021 |
|
NRIX
|
Gwenn Hansen
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 800 Reduced 6.25% |
$29,392
$36.74 p/Share
|
Feb 18
2021 |
|
NRIX
|
Pierre Beaurang
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$540,000
$36.0 p/Share
|
Feb 18
2021 |
|
TPB
|
Zimmerman Arnold |
SELL
Open market or private sale
|
Direct | 2,265 Reduced 100.0% |
$117,236
$51.76 p/Share
|
Feb 18
2021 |
|
TPB
|
Zimmerman Arnold |
SELL
Open market or private sale
|
Indirect | 2,735 Reduced 4.37% |
$141,564
$51.76 p/Share
|
Feb 18
2021 |
|
GUT
|
Mario J Gabelli
Director |
SELL
Open market or private sale
|
Indirect | 24,800 Reduced 10.51% |
$198,648
$8.01 p/Share
|
Feb 18
2021 |
|
AMRK
|
Brian Aquilino
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,305 Reduced 100.0% |
$38,380
$29.41 p/Share
|
Feb 18
2021 |
|
CVEO
|
Lance Torgerson
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 6,606 Reduced 0.18% |
$128,553
$19.46 p/Share
|
Feb 18
2021 |
|
KPTI
|
Jatin Shah
EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,186 Reduced 2.24% |
$17,588
$14.83 p/Share
|
Feb 18
2021 |
|
KPTI
|
Ran Frenkel
EVP, Chief Dev. Officer |
SELL
Open market or private sale
|
Direct | 2,887 Reduced 5.89% |
$42,814
$14.83 p/Share
|
Feb 18
2021 |
|
KPTI
|
Sharon Shacham
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 9,495 Reduced 1.21% |
$140,811
$14.83 p/Share
|
Feb 18
2021 |
|
KPTI
|
Sharon Shacham
Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect | 9,495 Reduced 1.62% |
$140,811
$14.83 p/Share
|
Feb 18
2021 |
|
KPTI
|
Michael Kauffman
Director |
SELL
Open market or private sale
|
Direct | 9,495 Reduced 1.62% |
$140,811
$14.83 p/Share
|
Feb 18
2021 |
|
KPTI
|
Michael Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 9,495 Reduced 1.21% |
$140,811
$14.83 p/Share
|
Feb 18
2021 |
|
EVER
|
Elyse Neumeier
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,860 Reduced 4.24% |
$89,001
$47.85 p/Share
|
Feb 18
2021 |
|
IMMR
|
Aaron Akerman
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,725 Reduced 21.15% |
$48,984
$13.15 p/Share
|
Feb 18
2021 |
|
DTIL
|
Derek Jantz
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 6,871 Reduced 0.17% |
$83,826
$12.2 p/Share
|
Feb 18
2021 |
|
DTIL
|
Matthew R. Kane
President and CEO |
SELL
Open market or private sale
|
Direct | 9,705 Reduced 0.51% |
$118,692
$12.23 p/Share
|
Feb 18
2021 |
|
WATT
|
Cesar Johnston
Director |
SELL
Open market or private sale
|
Direct | 6,306 Reduced 1.76% |
$24,152
$3.83 p/Share
|
Feb 18
2021 |
|
PCSA
|
James E Besser |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.44% |
$56,750
$11.35 p/Share
|
Feb 18
2021 |
|
EMAN
|
Stillwater Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 191,642 Reduced 25.76% |
$822,144
$4.29 p/Share
|
Feb 18
2021 |
|
EMAN
|
Ginola LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 46,364 Reduced 2.67% |
$195,656
$4.22 p/Share
|
Feb 18
2021 |
|
EMED
|
Donald J Steinberg
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 0.06% |
$1,173
$0.51 p/Share
|
Feb 18
2021 |
|
ALVR
|
Jeffrey S Bornstein |
SELL
Open market or private sale
|
Indirect | 20,583 Reduced 98.03% |
$840,404
$40.83 p/Share
|
Feb 18
2021 |
|
SEDG
|
More Avery
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 3.87% |
$1,265,400
$316.35 p/Share
|
Feb 18
2021 |
|
SSY
|
Christopher H B Mills |
SELL
Open market or private sale
|
Indirect | 44,308 Reduced 5.56% |
$103,238
$2.33 p/Share
|
Feb 18
2021 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 9,608 Reduced 0.04% |
$11,049
$1.15 p/Share
|
Feb 18
2021 |
|
KNWN
|
Ichiro John Paul Takesako
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 13.64% |
$101,400
$3.38 p/Share
|
Feb 18
2021 |
|
GDMK
|
Paul Adler
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.0% |
$424
$2.12 p/Share
|
Feb 18
2021 |
|
ONTF
|
Goldman Sachs Group Inc |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.0% |
$6,506
$65.06 p/Share
|
Feb 18
2021 |
|
IART
|
Tru St Partnership, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 70,275 Reduced 0.71% |
$5,000,066
$71.15 p/Share
|
Feb 18
2021 |
|
FBIO
|
Eric K Rowinsky
Director |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 0.81% |
$25,200
$4.2 p/Share
|
Feb 18
2021 |
|
MARA
|
Peter Benz
VP |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 82.12% |
$1,392,000
$46.4 p/Share
|
Feb 18
2021 |
|
LEGH
|
Curtis Drew Hodgson
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.38% |
$160,400
$16.04 p/Share
|
Feb 18
2021 |
|
LEGH
|
Douglas M Shipley
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.31% |
$160,400
$16.04 p/Share
|
Feb 18
2021 |
|
GCMG
|
Adage Capital Partners Gp, L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 0.47% |
$331,500
$13.26 p/Share
|
Feb 18
2021 |
|
SLNO
|
Jack W Schuler |
SELL
Open market or private sale
|
Indirect | 258,300 Reduced 2.38% |
$761,985
$2.95 p/Share
|
Feb 18
2021 |
|
AMTX
|
Todd Waltz
Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.7% |
$80,700
$8.07 p/Share
|
Feb 18
2021 |
|
ICCH
|
Rock Island Investors, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 53 Reduced 0.01% |
$758
$14.3 p/Share
|
Feb 18
2021 |
|
AMTX
|
Todd Waltz
Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.7% |
$88,000
$8.8 p/Share
|
Feb 17
2021 |
|
ICCH
|
Rock Island Investors, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 28 Reduced 0.01% |
$400
$14.3 p/Share
|
Feb 17
2021 |